Shore Capital reiterated their buy rating on shares of Experian (LON:EXPN – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports.
EXPN has been the topic of several other research reports. Jefferies Financial Group reissued a buy rating and set a GBX 4,020 ($51.09) target price on shares of Experian in a report on Thursday, April 18th. Barclays restated an overweight rating and issued a GBX 3,600 ($45.75) price objective on shares of Experian in a report on Friday, February 9th. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average price target of GBX 3,394 ($43.14).
View Our Latest Analysis on EXPN
Experian Stock Performance
Experian Increases Dividend
The business also recently announced a dividend, which will be paid on Friday, July 19th. Investors of record on Thursday, June 20th will be issued a $0.41 dividend. This represents a dividend yield of 0.93%. This is a boost from Experian’s previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, June 20th. Experian’s payout ratio is presently 4,466.02%.
Insider Activity
In related news, insider Jonathan Howell sold 2,318 shares of Experian stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of GBX 3,420 ($43.47), for a total value of £79,275.60 ($100,756.99). 0.18% of the stock is currently owned by company insiders.
Experian Company Profile
Experian plc, together with its subsidiaries, operates as a technology company in North America, Latin America, the United Kingdom, Ireland, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Business-to-Business and Consumer Services. The company collects, sorts, aggregates, and transforms data from various sources to provide a range of data-driven services.
Recommended Stories
- Five stocks we like better than Experian
- 3 Best Fintech Stocks for a Portfolio Boost
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Why Invest in Biotech Stocks
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- How to Use Stock Screeners to Find Stocks
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Experian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Experian and related companies with MarketBeat.com's FREE daily email newsletter.